india
-
ACM Global Central Laboratory establishes Mumbai-based subsidiary
ACM Global Central Lab has advanced its hybrid central lab model in Mumbai with an operational facility dedicated to manage clinical trials testing in India and provide study support throughout Asia Pacific.
india | 15 May 2012
-
Gerresheimer acquires Neutral Glass
Gerresheimer AG is committed to growth in the emerging markets. It acquires a majority shareholding in the Indian company Neutral Glass & Allied Industries to help it achieve this aim.
india | 19 April 2012
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
india | 28 March 2012
-
Phosphagenics licenses Diclofenac gel for Indian market
Phosphagenics has licensed TPM/diclofenac, its topical non-steroidal pain formulation, to Themis Medicare of Mumbai for the Indian market. This represents Phosphagenics’ first commercial deal in India and its first licensing agreement of its diclofenac product. Under the terms of the agreement, Themis Medicare is committed to pay Phosphagenics an undisclosed up-front fee and double-digit royalty payments on sales.
india | 06 January 2012
-
AMRI appoints new President, India Operations
Subramanyam Maddala assumes leadership for AMRI’s Indian API manufacturing operations as well as responsibility for AMRI facility operations in Hyderabad and Aurangabad, India.
india | 14 October 2011
-
India generics companies lead pharmaceutical innovation in Asia Pacific
Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.
india | 30 September 2011
-
Nutra Pharma receives regulatory approval to market Nyloxin in India
Nutra Pharma has received approval in India for its Nyloxin line of pain relievers.
india | 11 August 2011
-
VaxyGen Vaccines announces strategic collaboration with The Serum Institute of India
VaxyGen Vaccines Ltd announced the signing of a strategic collaboration agreement with the Serum Institute of India (SII). Under the terms of the agreement, VaxyGen Vaccines Ltd will have exclusive rights to commercialize certain SII approved and pip…
india | 29 June 2011
-
India attracting more investments in BioPharma R&D
More than 70 percent of the 40 global BioPharma executives in a recent survey are satisfied with their R&D alliances in India, and three out of four expect to increase their R&D activities in India. Despite such positive appraisals, India continues t…
india | 27 June 2011
-
Oceana Therapeutics announces strategic alliance with Dr Reddy in India
Oceana Therapeutics announced that it has entered into a multi-year exclusive agreement with Indian pharmaceutical giant Dr Reddy’s Laboratories Ltd giving rights to the sale and distribution of Deflux in India. Further terms of the transaction wer…
india | 17 May 2011
